Dartmouth-Hitchcock logo
Back
 
Medicine Grand Rounds - Endocarditis Related to Injection Drug Use: Marker of an Epidemic

Drs. Parsonnet and Kershaw share startling new statistics regarding the demographics and co-morbidities of patients presenting with endocarditis. Dr. Kershaw outlines the current treatment plans and their outcomes for PWID, especially looking at OPAT for select patient groups. She discusses moving from despair to hope by integrating addiction care into the overall plan when treating this challenging patient population.

Activity Details
Start Date:   April 19, 2019
End Date:  April 19, 2021

You may claim CME credit for successful completion of this online course. In order to claim credit, you must follow these steps:

  1. Register for the learning activity by creating an account or logging in to your account.
  2. Click Continue to navigate to the Activity Material tab. Click View Presentation to view the recording.
  3. Return to this Activity page.
  4. Click Continue to navigate to the Evaluation tab; then click the Launch button to start the evaluation.
  5. Complete and Submit the evaluation and attestation form.

When the evaluation is submitted, you will be awarded credit. You may access your transcript for verification of participation at any time via Your Account. Need help? Visit the Support Page, send an Email, or call the Center for Learning and Professional Development at (603) 653-1234, Option 1.

Presenters
  • Colleen Kershaw, MD
    Assistant Professor of Medicine
    Section of Infectious Disease and International Health
    Medical Director, Outpatient Parenteral Antimicrobial Therapy (OPAT) Program

    Dr. Colleen Kershaw received her MD from Georgetown University School of Medicine in Washington, DC, followed by training in Internal Medicine and subsequently fellowships in Global Health and Infectious Diseases at Beth Israel Deaconess Medical Center in Boston, MA.  She has a particular interest in the care of underserved and marginalized populations, the social determinants of health, and the intersection of addiction with infectious diseases.

  • Jeffrey Parsonnet, MD
    Professor of Medicine
    Section of Infectious Disease and International Health

    Dr. Jeffrey Parsonnet received his MD from the NYU School of Medicine, completed his Internal Medicine residency at Yale-New Haven Hospital and his Infectious Disease fellowship training in the combined Brigham and Women’s and Boston Beth Israel programs.  His primary research interest has been the epidemiology and pathogenesis of staphylococcal toxic shock syndrome and he has participated in the development of national guidelines for the diagnosis and treatment of Lyme disease.
Learning Outcome

Participants will be able to outline the changing epidemiology and natural history of endocarditis as it relates to injection drug use, describe new comprehensive approaches to treating endocarditis and addiction in patients who inject drugs (PWID), and outline local trends in drug-use associated endocarditis and initiatives for multidisciplinary care.

Accreditation

Dartmouth-Hitchcock is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Dartmouth-Hitchcock designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Requirements for Successful Completion

In order to receive credit for this Continuing Medical Education (CME) activity, you must:

  • View the entire presentation
  • Complete the online Attestation of Attendance & Evaluation Form (you must register to access).
Disclosure

In accordance with the disclosure policy of Dartmouth-Hitchcock/Geisel School of Medicine at Dartmouth as well as standards set forth by the Accreditation Council on Continuing Medical Education and the Nursing Continuing Education Council standards set forth by the American Nurses Credentialing Center Commission on Accreditation, continuing medical education and nursing education activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have been asked to disclose any financial relationship* they have to a commercial interest (any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients). Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide participants with information that might be of potential importance to their evaluation of a given activity.

The following Activity Physician Director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content for Endocarditis Related to Injection Drug Use: Marker of an Epidemic (Medicine Grand Rounds) have reported the following financial interest or relationship* with various companies/organizations. The Activity Director and Planning Committee member roles were resolved by altering the individual’s control over content about the products or services of the commercial interest by the Associate Dean for CME and the Department of Medicine Chair. All potential conflict(s) were resolved.

* Kelly Kieffer, MD ~ her spouse is a consultant for OcculoBio. 

* Richard I. Rothstein, MD ~ has research support from Baranova (research grant to Dartmouth-Hitchcock Medical Center) and has other financial interest from Allurion. 

Other planning committee member(s), speaker(s), activity director(s), author(s) or anyone in a position to control the content for this program report no financial interest or relationship* with any company(ies) or organizations whose product may be germane to the content of their presentations.

*A “financial interest or relationship" refers to an equity position, receipt of royalties, consultantship, funding by a research grant, receiving honoraria for educational services elsewhere, or to any other relationship to a company that provides sufficient reason for disclosure, in keeping with the spirit of the stated policy.

Provider Contact Information

Provider contact information for questions regarding accreditation of the activity:

Center for Learning and Professional Development
Dartmouth-Hitchcock Medical Center
clpd.support@hitchcock.org


Type:     Internet Activity (Enduring Material)
35 Registered Users

0